Fufeng Group (546.HK) Stock Price

Fufeng Group Ltd. generates revenue through its two primary business segments. The Amino Acid segment produces and sells monosodium glutamate, corn refined products, starch sweeteners, threonine, fertilizers, corn oil, glutamic acid, compound seasoning, pharmaceuticals, and concrete bricks. The Xanthan Gum segment focuses on manufacturing and selling xanthan gum. Products are sold to various industrial and consumer markets, with the amino acid products targeting food and agricultural sectors. The company's sales are driven by demand for these fermentation-based products across multiple applications. The company's Amino Acid segment includes a diverse range of products such as monosodium glutamate, threonine, and corn oil, which are used in food processing, animal feed, and pharmaceutical applications. Xanthan gum is utilized as a thickening agent in food and industrial applications. The firm's product portfolio serves both domestic and international markets, with sales concentrated in regions where bio fermentation products are in high demand. The company's revenue streams are derived from the consistent demand for these essential ingredients in food production and agriculture. Fufeng Group Ltd. manufactures and sells bio fermentation products through its two segments, leveraging its manufacturing capabilities to supply key ingredients for food, agriculture, and industrial applications. The Amino Acid segment's product range includes monosodium glutamate, starch sweeteners, and pharmaceuticals, while the Xanthan Gum segment provides xanthan gum for food and industrial use. The company's revenue is generated from the sale of these products to customers in the food processing, agricultural, and pharmaceutical industries.